Overlapping approach Proton Pump Inhibitors/Nux vomica-Heel as new intervention for gastro-esophageal reflux management: Delphi consensus study

Table 4 Voting results agreement for each individual statement in the Delphi consensus

	(1) Strongly disagree	(2) Disagree	(3) Undecided	(4) Agree	(5) Strongly agree	Sum votes 4-5	1st round consensus (reached if % greater than 66%)	2nd round consensus (reached if % greater than 66%)
Topic A: GERD disease
Statement 1 1st round	0/49	1/49	3/49	28/49	17/49	45	92
Statement 2 1st round	1/49	3/49	3/49	35/49	7/49	42	86
Statement 3 1st round	1/49	16/49	6/49	23/49	3/49	26	53
Statement 3 2nd round	3/40	9/40	0/40	26/40	2/40	28		70
Statement 4 1st round	1/49	2/49	1/49	25/49	20/49	45	92
Topic B: GERD treatment
Statement 5 1st round	0/49	2/49	3/49	36/49	8/49	44	90
Statement 6 1st round	0/49	1/49	1/49	39/49	8/49	47	96
Statement 7 1st round	0/49	2/49	2/49	30/49	15/49	45	92
Statement 8 1st round	0/49	1/49	3/49	32/49	13/49	45	92
Statement 9 1st round	1/49	1/49	1/49	30/49	16/49	46	94
Statement 10 1st round	0/49	0/49	2/49	36/49	11/49	47	96
Statement 11 1st round	0/49	0/49	0/49	30/49	19/49	49	100
Statement 12 1st round	0/49	1/49	3/49	33/49	12/49	45	92
Statement 13 1st round	0/49	0/49	0/49	33/49	16/49	49	100
Statement 14 1st round	0/49	1/49	2/49	32/49	14/49	46	94
Statement 15 1st round	0/49	2/49	2/49	35/49	10/49	45	92

GERD: Gastro-esophageal reflux disease.